Since the analysis of serum S100B showed the highest sensitivity and specificity of all tumour markers examined in CM and it is fairly inexpensive, numerous clinicians include its measurement in routine follow up of CM patients [7,19]. This evidence concerns the gene S100B and cutaneous mastocytosis.